尽管投资者出售,Johnson & Johnson仍然报告收入丰厚,超过分析师的估计。 Despite investor sell-offs, Johnson & Johnson reported strong earnings, exceeding analysts' estimates.

Johnson & Johnson(JNJ)看到一些投资者减少了在问题4中持有的股份,其中包括第一基金会顾问,他们出售了3 675股股份,将其股份减少到47 050股。 Johnson & Johnson (JNJ) saw several investors reduce their holdings in Q4, including First Foundation Advisors, which sold 3,675 shares, reducing its stake to 47,050 shares. JNJ 报告称，季度收益强劲，达到每股 2.04 美元，超出分析师的预期 0.05 美元，营收 225.2 亿美元，也超出预期。 JNJ reported strong quarterly earnings of $2.04 per share, beating analysts' estimates by $0.05, with revenue of $22.52 billion also exceeding expectations. 该公司通过创新医学和医疗技术部分经营。 The company operates through Innovative Medicine and MedTech segments. JNJ股份的50天移动平均数为159.50美元,200天移动平均数为15537美元。 Shares of JNJ have a 50-day moving average of $159.50 and a 200-day moving average of $155.37. 美国银行保持了“中性”评级,但将价格目标降低到159.00美元。 Bank of America maintained a "neutral" rating but lowered the price target to $159.00.